date:Jan 14, 2014
so that it can better target the lower end of the market and cover mostly the third- or even fourth-tier cities, said Song Liang, a dairy analyst at the Distribution Productivity Promotion Center of China Commerce.
To respond to the country's call for industry consolidation, Hong Kong-based Biostime announced earlier this month it had purchased Changsha Yingke, a licensed domestic infant formula producer, for 350 million yuan ($57.4 million), which is expected to give Biostime an additional 30